Skip to main content
Back to Google Ventures

Google Ventures's Therapeutics Portfolio

Browse 31 Therapeutics companies funded by Google Ventures. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
31
Total Funding in Therapeutics
$2.8B

Therapeutics Portfolio Companies (31)

Export
BiotechnologyLife ScienceTherapeutics

Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives.

San Francisco, United States
July 2022
$65.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Pretzel Therapeutics mission is to develop groundbreaking therapies to reverse mitochondrial dysfunction through mitochondrial biology.

Waltham, United States
July 2025
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Evelo Biosciences is a biotechnology company that develops oral biologics for small intestinal axis with systemic therapeutic effects.

Cambridge, United States
July 2023
$25.5M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareOncologyTherapeutics

IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.

South San Francisco, United States
June 2026
$345.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Health CareMedicalTherapeutics

Delphia Therapeutics operates and manages a laboratory that develops treatments for cancer cells.

Cambridge, United States
May 2024
$67.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.

Cambridge, United States
May 2026
$275.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyFertilityHealth CareTherapeutics

Granata Bio is a biotechnology company developing therapeutic solutions to address infertility and improve women's reproductive health.

Duxbury, United States
May 2025
Corporate Round

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Merida Biosciences is a biotech company focused on developing precision treatments, particularly for autoimmune diseases.

Cambridge, United States
April 2025
$121.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsLife ScienceTherapeutics

LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.

Cambridge, United States
March 2022
$175.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Spotlight Therapeutics is a biotechnology company that develops biologics targeted to specific cell populations in gene editing.

Hayward, United States
March 2022
$36.5M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsTherapeutics

Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology.

Cambridge, United Kingdom
March 2026
$40.0M
Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Vir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions.

San Francisco, United States
February 2026
$150.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Life SciencePharmaceuticalTherapeutics

Perceive Pharma operates as a pharmaceutical company.

San Francisco, United States
February 2025
$15.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.

Bernardsville, United States
February 2024
$75.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Santa Ana Bio is a biotechnology company focusing on precision immunology for autoimmune and inflammatory diseases.

Alameda, United States
June 2024
$125.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalPharmaceuticalTherapeutics

Accent Therapeutics is a biopharmaceutical company.

Lexington, United States
January 2024
$75.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

TenSixteen Bio is a biotechnology company focused on developing novel therapeutics for a variety of diseases.

San Francisco, United States
January 2022
$40.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth DiagnosticsTherapeutics

Denali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.

San Francisco, United States
December 2025
$200.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical DeviceTherapeutics

Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.

Cambridge, United States
December 2022
$25.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.

Boston, United States
December 2022
$60.0M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareTherapeutics

Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.

San Francisco, United States
December 2025
$60.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Rhygaze develops a novel gene therapy that targets cone cells to restore vision in patients suffering from diseases causing blindness.

Basel, Switzerland
January 2025
$86.0M
Series A

Founder Contacts

30,000+ verified contacts

Health CareMedicalPharmaceuticalTherapeuticsWellness

Pelage Pharma is a regenerative medicine biotechnology company developing treatments for hair loss.

Los Angeles, United States
October 2025
$120.0M
Series B

Founder Contacts

30,000+ verified contacts

Health CareMedicalMental HealthTherapeutics

Syremis Therapeutics is developing novel medicines to make a profound impact on the treatment of mental health disorders.

Tel Aviv, Israel
December 2025
$165.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.

Waltham, United States
December 2024
$30.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedicalNeuroscienceTherapeutics

Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases.

Boston, United States
April 2024
$47.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyMedical DeviceTherapeutics

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.

Cambridge, United States
September 2022
$9.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalPharmaceuticalTherapeutics

Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing immunotherapies for infectious diseases and cancer.

Harwell, United Kingdom
March 2021
$168.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Locana develops RNA-targeting gene therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.

San Diego, United States
December 2020
$100.0M
Series B

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareNeuroscienceTherapeutics

BlackThorn Therapeutics is a clinical-stage neurobehavioral health company pioneering the next generation of artificial intelligence.

San Francisco, United States
June 2019
$76.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Rodin Therapeutics develops novel therapeutics for neurological disorders by applying insights of epigenetics.

Cambridge, United States
September 2017
$27.0M
Series C

Founder Contacts

30,000+ verified contacts

Explore Google Ventures's Full Portfolio

View all companies funded by Google Ventures across every industry and funding stage.

View Full Google Ventures Portfolio